neurosurgical focus
sion fracture. 3, 20, 22 Prolonged steroid use, female sex, older age, and smoking also increase fracture risk. 11, 19, 27, 34 Treatment with bisphosphonates improves bone density and decreases fracture risk in patients with and without previous vertebral fractures. 2, 8 Lower bone mineral density and previous vertebral fractures are independent major risk factors for future osteoporotic fractures. 5, 9, 38 Patients with previous vertebral fractures treated with vertebral cement augmentation are at an increased risk of repeat fracture at another level, especially the adjacent level. 23, 33, 41 This association was suggested in a cohort study to be stronger in the thoracic spine than in the lumbar spine. 40 Early treatment of osteoporosis in the elderly is essential to prevent complications such as hip fractures, which have a 1-year postevent mortality rate of up to 20%. 1, 7 Randomized controlled trials have confirmed that medical treatment of osteoporosis significantly increases bone density, reduces fracture incidence, and slows progression of spinal deformity and height loss in women with vertebral fractures and/or postmenopausal women. 2, 13, 24 The National Osteoporosis Foundation recommends bone density testing for all patients with a diagnosis of osteoporotic fracture, especially those fractures associated with minimal or no trauma. 30 Initiation of medical treatment is recommended for all patients who have been diagnosed with hip or vertebral body fractures, regardless of bone density scan findings.
14,30 Overwhelmingly inadequate diagnostic evaluation and treatment of patients presenting with low-impact fractures has been reported for hip, humerus, and spine fractures, 31, 39 as well as distal radius fractures.
14 Osteoporosis is rarely addressed or listed as a secondary diagnosis at the time of discharge in patients with low-impact fractures, even in the classically highrisk population of postmenopausal, elderly white women. 29, 36 Literature from both orthopedic surgery and internal medicine groups has demonstrated severe deficits in point-of-care secondary prevention interventions among patients presenting with low-impact, likely osteoporotic fractures. 6, 14, 31, 39 Similar data are not available from academic neurosurgery groups.
Our aim in this study was to evaluate and address medical treatment of osteoporosis in patients undergoing vertebral augmentation at our academic neurosurgery department. A diagnosis of osteoporosis can be acquired by either a disease-defining fracture (including a vertebral compression fracture, in the setting of low or no impact) or a DEXA scan demonstrating a t-score of -2.5 or less (i.e., a bone density that is 2.5 standard deviations below that of the average 30-year-old woman). In the case of our patients who had all been diagnosed and surgically treated for osteoporotic vertebral fractures, the goal according to the guidelines would be that all such patients receive medical treatment, such as bisphosphonates. First, we hypothesized that point-of-care osteoporosis-directed diagnostic and therapeutic measures were adequately implemented in less than 50% of patients who undergo kyphoplasty procedures performed by our neurosurgery service. Second, we hypothesized that no significant difference in diagnostic and therapeutic compliance with current medical management guidelines would be found between patients referred for neurosurgical intervention by a medical specialist, such as a primary care provider, and those encountered directly with a diagnosis of compression fracture by the neurosurgery service, such as through the emergency room.
methods
Using the outpatient electronic medical record system (Medent) for the neurosurgery department, we identified all patients who underwent percutaneous kyphoplasty for compression fractures by our neurosurgery group between January 1, 2010, and January 1, 2012, using the following current procedural terminology codes (American Medical Association): 22523, 22524, 22525, 72291, and 72292. We performed detailed electronic chart reviews and tabulated several independent and dependent variables ( Table  1 ). Diagnostic and therapeutic interventions were counted as performed regardless of whether they were performed before or after the encounter with our department and diagnosis of fracture. We used a 2-tailed Fisher's exact 2 × 2 contingency table to statistically analyze all variables except age. The correlation between patient age and other variables was analyzed using univariate logistic regression. This study was conducted in accordance with a HIPAA-compliant, institutional review board-approved protocol.
results
A total of 108 patients underwent vertebral cement augmentation for compression fractures during the study period. Three of these patients were excluded from our analysis as the pathology findings were consistent with malignant disease (breast cancer, lung cancer, and lymphoma, respectively). Another patient treated for a compres sion fracture after a high-speed motor vehicle collision was excluded because this fracture was not considered osteoporotic.
Predictors of compliance and surgery characteristics are described in Table 2 . The percentage of patients who received osteoporosis-related treatments was < 50% for all interventions (Table 3) . DEXA screening was performed in only 10% of the patients who had undergone kyphoplasty. Only 13% of patients were treated with bisphosphonates. An overwhelming majority (94%) of these patients were white, and our population was insufficiently diverse to analyze race for statistical significance. Medicare was the primary insurance provider for most patients ( Table 4) . The average age of the patients was 77.1 ± 12.8 years. Age was not found to correlate with other variables (Table 5) .
Patients first encountered by the department in the outpatient setting were more likely to have at least 1 lumbar fracture compared with those who were examined for the first time in the hospital ( Table 2) . Patients with a medical history of unprovoked fractures were more likely to have undergone multiple surgeries compared with patients who had a known history of minor trauma. Nevertheless, no significant association could be established between injury mechanism, initial encounter in the emergency room versus outpatient setting, steroid use, smoking history, and sex on the one hand, and most parameters of osteoporosis evaluation and therapy on the other hand.
Patients referred by a specialist other than the primary care provider were significantly more likely to have been screened with a DEXA scan, to have had more than 1 fractured level, and to have been treated with vitamin D and calcium (Table 2 ). No significant difference was noted in the rate of treatment with bisphosphonates or parathormone.
Conversely, patients evaluated for preoperative clearance by their primary care provider were more likely to have been treated with bisphosphonates than those evaluated by an in-house hospitalist only (Table 2) . However, no significant association could be established in other parameters of osteoporosis treatment and screening. 
discussion
Previous literature has reported bone density screening in < 3% to 38% of patients discharged from hospitals with known osteoporotic fractures; and appropriate medical therapy, such as bisphosphonates or parathormone, in 22%-38%.
6,14,31,39 DEXA screening was performed in 10% of patients in our cohort; vitamin D, calcium, and bisphosphonate therapy were documented in 38%, 26%, and 13% of our cohort, respectively.
No statistical significance was noted in most treatment parameters, regardless of whether the patient was referred to the outpatient setting or evaluated in the emergency room first. Patients with unprovoked fractures were more likely to undergo multiple surgeries compared with those with minor trauma, perhaps indicating a more fragile state predisposing to further spontaneous fractures. Referral from a specialist rather than a primary care physician was associated with statistically significant improvement in compliance with bone density screening, as well as vitamin D and calcium therapy. One can theorize that this may be because the patient's chart had been reviewed by more than 1 physician and perhaps by subspecialists, thereby increasing episodes of physician-patient interaction and opportunities for implementing therapies. This same group, referred by specialists other than the primary care provider, was more likely to have multiple fractures, raising the possibility that their disease process was more advanced or medically complex, thus encouraging primary care providers to seek specialist involvement. Nevertheless, even these medical measures were all suitable merely for fracture prevention. The standard of care for every patient in our cohort with vertebral compression fractures is treatment with bisphosphonate therapy or parathormone. All groups were poorly compliant with this therapy. Although patients who underwent preoperative evaluation by their primary care physician were significantly more likely to receive bisphosphonates compared with those only evaluated by a hospitalist, the former group was only 21% compliant. Shortcomings of our cohort evaluation include lack of pretest power analysis and the retrospective nature of our data. We have not analyzed dosing and drug regimen as part of our study; we maintain that this would be premature because of the overall poor compliance. We reported several variables, including patient referral source, initial setting of neurosurgical evaluation, and setting of preoperative evaluation (Table 1) . Although aimed at representing the various stages of patient interaction, the exact implication of our categories is unclear and their external validity is questionable. Unique patient experiences are difficult to quantify, and detailed patient interviews may enable a qualitative evaluation of the sources of low compliance. In reporting the data for our cohort, we were attempting to identify various possible physician referral and evaluation sequences and schemas. Unfortunately, no single scheme was overwhelmingly successful in implementing the appropriate osteoporosis therapies.
Compliance was generally poor despite evaluation by multiple teams including, in various combinations, an outpatient primary provider, an outpatient medical specialist, an inpatient medical hospitalist team, and the neurosurgery team. Although tempting, it would be inappropriate to lay blame with any single team. The inpatient hospitalist may not see management of a chronic disease like osteoporosis to be the purpose of his or her consultation and may limit comments to perioperative cardiovascular risk assessment. The primary care physician may not be kept abreast of an acute diagnosis of fracture and is not the primary provider at the point of care, especially if the patient presents to the hospital emergency room. The neurosurgeon, although clearly at the forefront of the point-ofcare patient interaction, may not see medical management of osteoporosis as a part of his or her scope of expertise or purview of care.
Three categories of solutions may be proposed: systems-based solutions, personnel-based solutions, and comprehensive interdisciplinary physician behavior modification interventions. A systems-based solution would, most likely, rely on outpatient and/or inpatient health record technology to create an automatically generated reminder or recommendation when patients who have undergone kyphoplasty visit the department. This can be performed via extant mechanisms in most updated outpatient and inpatient electronic health record systems. Depending on the scope and particular arrangement of the practice or hospital, the nature of the reminder could be a recommendation to start a medication, an automated letter to the patient's primary care provider reminding them of the current guidelines, or a streamlined referral to an endocrinologist.
A personnel-based solution would consist of a dedicated osteoporosis specialist-whether a physician, a midlevel provider, or a clinical pharmacist-who would be entrusted with ensuring medical care of patients with osteoporotic fractures. After being automatically notified of all patients undergoing vertebral augmentation, the dedicated osteoporosis specialist's role could include direct patient counseling, treatment regimen design and prescription, and/or recommending treatment protocols to the primary surgeon.
Systematic interventions with quantifiable outcomes to affect physician behavior modification have been reported in many fields, often with success.
4,32 These performance improvement interventions, which often demand interdisciplinary cooperation, may include educational materials, training workshops, lectures, audit/feedback mechanisms, and physician opinion leaders, among others. Such projects are time intensive, costly, and may be sustainable for the timeframe of the measured outcomes with diminishing compliance thereafter. Yet, they provide a systematic intervention paradigm and quantifiable outcome measures that can be shared with the academic and scientific community. Despite these advantages, the reproducibility and external validity of such data are suspect because such interventions are usually tailored to particular practice patterns, personalities, and academic environments.
conclusions
We report poor compliance with recommended medical therapies among patients with osteoporotic compression fractures undergoing kyphoplasty. Further studies are required to analyze barriers to care. Systems-based, personnel-based, and physician behavior modification intervention options may improve compliance with screening and treatment guidelines in patients with vertebral compression fractures referred to the neurosurgery service for percutaneous cement augmentation procedures. 
